Hologic,
Inc. today announced the launch of its next-generation, FDA approved NovaSure® ADVANCED global endometrial ablation
(GEA) system in the United States.
Hologic,Inc. is a leading developer, manufacturer and supplier of premium diagnostic
products, medical imaging systems and surgical products.
NovaSuresystem is designed to ablate the endometrium by applying radiofrequency energy to
the endometrium thereby reducing the Abnormal Uterine Bleeding (AUB). It first received approval from FDA in 2001 and since then nearly 2 million women have been benefited by the procedure of endometrial ablation.
The new
generation comes with smaller 6 mm
Diameter sheath vs. 8 mm to improve patient comfort because of lesser cervical dilatation
required for the procedure.
Additional feature of the updated
device includes an acorn-like shaped cervical seal that creates an increased
sealing surface within the cervical canal and provides 13% more "working
length" than the previous model. It also includes rounded Smooth
Access™ tips to simplify insertion that requires less manipulation and blue handle that serves as a useful reminder for how the device should be
inserted.
The ablation procedure does not lasts more
than 2 minutes.
Dr. Edward Evantash, Medical Director,
Hologic says "The next-generation NovaSure ADVANCED system promises the
same efficacy and safety profile that physicians have trusted for more than 10
years."
The NovaSure ADVANCED system was launched in Europe, Canada and Australia in 2016.
NovaSure ADVANCED Product Demo
NovaSure ADVANCED Physician
Testimonials
